西藏药业跌2.07%，成交额4.03亿元，主力资金净流出5876.25万元

Group 1 - The core viewpoint of the news is that Tibet Pharmaceutical's stock has experienced fluctuations, with a recent decline of 2.07% and a year-to-date increase of 48.54% [1] - As of September 17, the stock price is 52.09 yuan per share, with a total market capitalization of 16.79 billion yuan [1] - The company has seen a net outflow of main funds amounting to 58.76 million yuan, with significant selling pressure observed [1] Group 2 - For the first half of 2025, Tibet Pharmaceutical reported a revenue of 1.651 billion yuan, reflecting a year-on-year growth of 2.23%, while the net profit attributable to shareholders decreased by 8.96% to 567 million yuan [2] - The company has distributed a total of 2.258 billion yuan in dividends since its A-share listing, with 1.580 billion yuan distributed over the past three years [3] - As of June 30, 2025, the number of shareholders decreased by 8.08% to 45,200, while the average circulating shares per person increased by 8.79% to 7,132 shares [2]